Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03709758
Recruitment Status : Recruiting
First Posted : October 17, 2018
Last Update Posted : June 24, 2019
Sponsor:
Collaborators:
AbbVie
Genentech, Inc.
Information provided by (Responsible Party):
Richard Stone, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 1, 2023
Estimated Study Completion Date : June 1, 2025